Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and all the other applicable provisions thereto, Eiko Lifesciences has attached the press release relating to Acquisition of 51% equity stake in SSM Formulations (SSM), a Hinganghat Wardha based pharmaceutical formulations company.
The above information is a part of company’s filings submitted to BSE.